Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Maccabi Healthcare Services, Israel
ClinicalTrials.gov Identifier:
NCT01779115
First received: January 28, 2013
Last updated: January 30, 2013
Last verified: January 2013

January 28, 2013
January 30, 2013
January 1998
December 2100   (final data collection date for primary outcome measure)
Prevalence rates of Diabetes [ Time Frame: Up to 100 years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01779115 on ClinicalTrials.gov Archive Site
  • Rates of performance of eye examinations,blood and urine tests [ Time Frame: up to 100 years ] [ Designated as safety issue: No ]
  • Number and types of Drugs purchased [ Time Frame: 100 years ] [ Designated as safety issue: No ]
  • Number of visits to physician offices [ Time Frame: up to 100 years ] [ Designated as safety issue: No ]
  • Performance of eye examinations,blood and urine tests [ Time Frame: up to 100 years ] [ Designated as safety issue: No ]
  • Drugs purchase [ Time Frame: 100 years ] [ Designated as safety issue: No ]
  • physician visits [ Time Frame: up to 100 years ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel
Computerized Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel

A computerized registry of diabetes patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify diabetes patients and to follow the courses of their illnesses and risk factors.

The registry was initiated in 1998 by Maccabi Healthcare services, which is the second largest publicly funded HMO in Israel,serving 24% of the total population with a nationwide distribution.

The registry uses advanced information technology that integrates personal computerized community and hospital records, data from laboratory tests, dispensed medications, physiological signals, radiological images, and reports from investigations and procedures.

Observational [Patient Registry]
Observational Model: Case-Only
1 Month
Not Provided
Non-Probability Sample

Diabetes patients.

  • Type 1 Diabetes
  • Type 2 Diabetes
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
126000
Not Provided
December 2100   (final data collection date for primary outcome measure)

Inclusion Criteria:

Diabetic patient was defined according to the criteria suggested by American Diabetes Association - symptoms diagnosed as diabetes and fasting plasma glucose >125 mg/dl (7.0 lmol/l) or casual (namely, any time of day without regard to time since last meal) plasma glucose concentration P200 mg/dl. In order to reach maximal validity, we also included any patient who answered to one of the following: (1) purchased at least two hypoglycemic medications or single insulin dose during 6 months. (2) Had HbA1c result of at least 7.25%. HbA1c of 6.5% was used as entry criterion to registry only when the patient was diagnosed as diabetic.

Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
NCT01779115
MACCVREGDIAB
Yes
Maccabi Healthcare Services, Israel
Maccabi Healthcare Services, Israel
Not Provided
Study Director: Gabriel Chodick, PHD Head,Epidemiology & Database Reseaech Unit, Medical Division, Maccabi H.S
Maccabi Healthcare Services, Israel
January 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP